{"id":"https://openalex.org/W7204995638","doi":"https://doi.org/10.1158/2326-6066.33414671","title":"Supplementary Video S3 from CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance","display_name":"Supplementary Video S3 from CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance","alternate_titles":[],"publication_year":2026,"publication_date":"2026-09-02","ids":{"openalex":"https://openalex.org/W7204995638","doi":"https://doi.org/10.1158/2326-6066.33414671"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.33414671","doi":"https://doi.org/10.1158/2326-6066.33414671","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.33414671","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W7204995638"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.33414671","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028021563","display_name":"Tiffany R. King-Peoples","orcid":"https://orcid.org/0000-0002-9993-0560","observed_orcids":["https://orcid.org/0000-0002-9993-0560"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tiffany R. King-Peoples","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9993-0560","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038190447","display_name":"John T. Keane","orcid":"https://orcid.org/0009-0002-0994-5038","observed_orcids":["https://orcid.org/0009-0002-0994-5038"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John T. Keane","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-0994-5038","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089058357","display_name":"Hyeon-Gyu S. Lewis","orcid":"https://orcid.org/0009-0001-2797-8813","observed_orcids":["https://orcid.org/0009-0001-2797-8813"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hyeon-Gyu S. Lewis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-2797-8813","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103273993","display_name":"Fang Liu","orcid":"https://orcid.org/0009-0004-9031-7032","observed_orcids":["https://orcid.org/0009-0004-9031-7032"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fang Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-9031-7032","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005099310","display_name":"Shawna K. Brookens","orcid":"https://orcid.org/0000-0003-1620-6276","observed_orcids":["https://orcid.org/0000-0003-1620-6276"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shawna K. Brookens","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1620-6276","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010100514","display_name":"Oula K. Dagher","orcid":"https://orcid.org/0000-0003-3505-5282","observed_orcids":["https://orcid.org/0000-0003-3505-5282"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Oula K. Dagher","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3505-5282","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073593508","display_name":"Kalpana Parvathaneni","orcid":"https://orcid.org/0000-0002-0963-665X","observed_orcids":["https://orcid.org/0000-0002-0963-665X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kalpana Parvathaneni","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0963-665X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086127623","display_name":"Brittany L. Gardner","orcid":"https://orcid.org/0009-0000-8661-1109","observed_orcids":["https://orcid.org/0009-0000-8661-1109"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brittany L. Gardner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-8661-1109","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063744182","display_name":"Amal Ahmed","orcid":"https://orcid.org/0009-0000-9310-1297","observed_orcids":["https://orcid.org/0009-0000-9310-1297"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amal Ahmed","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-9310-1297","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042763431","display_name":"Emma Elizabeth Furth","orcid":"https://orcid.org/0000-0002-9309-985X","observed_orcids":["https://orcid.org/0000-0002-9309-985X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emma E. Furth","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9309-985X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046655398","display_name":"Priti Lal","orcid":"https://orcid.org/0000-0002-5839-8205","observed_orcids":["https://orcid.org/0000-0002-5839-8205"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Priti Lal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5839-8205","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081974926","display_name":"Avery D. Posey","orcid":"https://orcid.org/0000-0001-8711-629X","observed_orcids":["https://orcid.org/0000-0001-8711-629X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Avery D. Posey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8711-629X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.03180000185966492,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6930000185966492},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.8610000014305115},{"id":"https://openalex.org/keywords/tumor-resistance","display_name":"tumor resistance","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6888999938964844},{"id":"https://openalex.org/C73588182","wikidata":"https://www.wikidata.org/wiki/Q2663023","display_name":"Cytolysis","level":4,"score":0.666700005531311},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6646000146865845},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5458999872207642},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5299999713897705},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.517799973487854},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.42329999804496765},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.37389999628067017},{"id":"https://openalex.org/C86492073","wikidata":"https://www.wikidata.org/wiki/Q413766","display_name":"Fibronectin","level":3,"score":0.36739999055862427},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.35100001096725464},{"id":"https://openalex.org/C14527384","wikidata":"https://www.wikidata.org/wiki/Q4693403","display_name":"Agonism","level":3,"score":0.33340001106262207},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.32820001244544983},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3203999996185303},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.28700000047683716},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.28459998965263367},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2685999870300293},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.26660001277923584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2651999890804291},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2597000002861023},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.2538999915122986}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.33414671","doi":"https://doi.org/10.1158/2326-6066.33414671","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.33414671","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.33414671","doi":"https://doi.org/10.1158/2326-6066.33414671","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.33414671","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7205015219","https://openalex.org/W7167288129","https://openalex.org/W4308379966","https://openalex.org/W7096729674","https://openalex.org/W3167988724","https://openalex.org/W2746664911","https://openalex.org/W4362539571","https://openalex.org/W2514392303","https://openalex.org/W1988989410","https://openalex.org/W4225412053"],"abstract_inverted_index":{"Real-time":[0],"cytotoxicity":[1],"of":[2],"L19-BBz":[3],"T":[4],"cells":[5],"against":[6],"GFP+":[7],"PC3":[8],"targets.":[9]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204995638","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-09-02T00:00:00"}
